US8592581, 12

ID: ALA3655773

Chembl Id: CHEMBL3655773

PubChem CID: 25020437

Max Phase: Preclinical

Molecular Formula: C20H29N7O

Molecular Weight: 383.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](Nc1nc(NCc2cccc(C)n2)c2ncn(C(C)C)c2n1)[C@@H](C)O

Standard InChI:  InChI=1S/C20H29N7O/c1-6-16(14(5)28)24-20-25-18(21-10-15-9-7-8-13(4)23-15)17-19(26-20)27(11-22-17)12(2)3/h7-9,11-12,14,16,28H,6,10H2,1-5H3,(H2,21,24,25,26)/t14-,16+/m1/s1

Standard InChI Key:  JYLHONINWOWQPB-ZBFHGGJFSA-N

Associated Targets(Human)

CDK9 Tchem Cyclin-dependent kinase 9 (2495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2 (9050 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.50Molecular Weight (Monoisotopic): 383.2434AlogP: 3.29#Rotatable Bonds: 8
Polar Surface Area: 100.78Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.21CX LogP: 2.30CX LogD: 2.30
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.55Np Likeness Score: -1.03

References

1.  (2013)  Trisubstituted purine derivatives, 

Source

Source(1):